US Patent Issued to Alcon on Nov. 11 for "Hybrid 2-port vitrectomy and combined treatment and infusion probe" (Texas Inventor)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,465,521, issued on Nov. 11, was assigned to Alcon Inc. (Fribourg, Switzerland).

"Hybrid 2-port vitrectomy and combined treatment and infusion probe" was invented by Paul R. Hallen (Colleyville, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure generally relates to microsurgical instruments for ophthalmic surgical procedures, and more particularly, methods and microsurgical instruments for vitreoretinal procedures. In certain embodiments described herein, a vitreoretinal procedure is performed utilizing two surgical instruments: 1) a treatment instrument configured to a) treat a target ophthalmic tissue (e.g., sever and remove t...